Wacker Opens New Chinese Headquarters in Shanghai

Wacker Chemie officially opened its new company headquarters for the Greater China region (Mainland China and Taiwan) in Shanghai today. The new Shanghai Center, which occupies some 10,000 square meters, features offices for marketing, sales and administrative functions along with numerous laboratories for R&D and applications technology.

Applications range from dry-mix mortars and exterior insulation and finish systems for construction purposes, to paints and coatings, through to products for the automotive, cosmetics and textile sectors.

In launching the new research and testing laboratories in collaboration with its customers, the Munich-based chemical group is seeking to further expand its technology leadership in high-quality silicone and polymer products for the Chinese market.

During a press conference in Shanghai on Friday, CEO Staudigl stressed the strategic importance of China as a growth market for Wacker. "The Greater China region has evolved into our single most important market. China is the world's largest chemical market. We expect Chinese demand for high-quality chemical products to keep rising in the years ahead."

Last year, Wacker's roughly 900 employees in China and Taiwan generated sales of €1.03 billion, or around one-fifth of the Group total.

Referring to the ongoing investigations in the USA, Europe and China concerning the imposition of tariffs on solar products, Staudigl reaffirmed his opposition to trade barriers. "We were one of the first to speak out against any kind of protectionism because, in a trade war, there can only be losers," he said.

"Low prices are the reason why solar products have been successful on a global scale. Consequently, any money that has to be spent on punitive tariffs cannot go toward research and innovation. That would artificially raise the price of solar products and slow down the global shift toward renewable energy sources. Wacker will continue to do all it can to ensure that any contentious issues are resolved through negotiation, just as German Chancellor Angela Merkel said on a recent trip to Beijing."

Having operated its own subsidiary in Greater China for 20 years now, Wacker has greatly expanded its activities in the region over recent years. Investments in China to date come to around €400 million. This figure is set to exceed €600 million in the next four years.

Wacker has eight sales offices in the most important economic regions of China, as well as two technical centers and four production sites. Its Zhangjiagang and Nanjing sites produce silicones, disper-sions and dispersible polymer powders.

To meet strong demand growth from customers, Wacker is currently doubling its dispersions production capacity in Nanjing to 120,000 metric tons per year. The additional capacity is primarily intended for paints, coatings and adhesives.

Wacker is also building a new polyvinyl acetate (PVAc) plant there with an annual production capacity of 20,000 metric tons. Both plants are scheduled to come on stream next year.

 

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

most read

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.